by Isaac Eliaz, MD, MS, LAc
This review summarizes the pathophysiological connection of galectin-3 and cancer presently in the literature, as well as the potential clinical value of galectin-3 as a prognostic oncology biomarker. Based on the preliminary data, the galectin-3 assay could become a contributing tool to help clinicians monitor treatment response and tumor progression, but further clinical studies evaluating galectin-3 levels and cancer progression are warranted.
by Kurt Beil, ND, LAc, MPH
This cross-sectional analysis, comparing mental health status with neighborhood green space, found that green space significantly reduced 3 measures of depression according to participant responses to the Depression, Anxiety and Stress Scale.
by Julia Osborne, PT, CLT-LANA
Lymphedema affects many breast cancer patients. In this randomized trial, complete congestion therapy with a focus on manual lymph drainage was tested vs the use of compression garments to reduce lymphedema in 95 women being treated for breast cancer.
by Landon Opunui, ND
In a recent study, Epstein Barr virus patients who received intravenous vitamin C demonstrated decreased levels of antigens in the acute state of disease and alleviation of symptoms of the infection.
by Bill Walter, ND
First published in 1996, this book aims to help students easily understand key concepts in evidence-based medicine and explain the logic and methodology of this approach. This year marks the publication of the fifth edition of the book, which has become a core textbook in medical schools around the world.
by Tina Kaczor, ND, FABNO
In this interview with naturopathic oncology specialist Adam Kerievsky, ND, LAc, FABNO, we discuss the risk factors for triple-negative breast cancer, the treatment challenges it poses for practitioners, and complementary therapies that may benefit patients battling this cancer.